U.S. says Glaxo drug may be linked to birth defect
(Re


Reuters - Taking GlaxoSmithKline Plc's
Lamictal epilepsy drug during the first three months of
pregnancy may increase the chances of having a baby with a
cleft lip or palate, U.S. regulators warned on Friday.